Medstar Health Research Institute
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Medstar Health Research Institute sits in the top decile of US sponsors by registered trial count (#223 of 15,742 sponsors by registered trial count).
Medstar Health Research Institute: 115 sponsored US clinical trials, 23 recruiting.
Medstar Health Research Institute sponsors 115 registered US clinical trials on ClinicalTrials.gov, 23 of them currently recruiting, and 65 completed. 16 of these trials are in Phase 3-4 (later-stage) and 18 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Neurogenic Bladder, with 5 trials.
Top-decile sponsor footprint
Medstar Health Research Institute ranks in the top decile of sponsors by registered trial count (#223 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
65 of 83 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (78.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
115 total, page 3 of 3
Solid Tumors Using Ixabepilone and Dasatinib
NCT00717704
Sutent Adjunctive Treatment of Differentiated Thyroid Cancer
NCT00668811
Stop Emergency Room Visits for Hyperglycemia Project - District of Columbia (DC)
NCT01033773
Eptifibatide and ST Segment Resolution Following Primary PCI
NCT00812435
Switching From Fondaparinux to Bivalirudin or Unfractionated Heparin in ACS Patients Undergoing PCI
NCT00464087
Platelet Reactivity After Cessation of Clopid in the Setting of Coronary Stent Implantation I: PRACTICE I
NCT00684359
Efficacy Study of Vaginal Mesh for Anterior Prolapse
NCT00557882
Efficacy Study of Vaginal Mesh for Prolapse
NCT00475540
Ppar-Gamma EliminAtes Restenosis Longevity Study: PEARLS
NCT00465296
Carotid With Bivalirudin Angioplasty
NCT00812383
Conservative Versus Liberal Red Cell Transfusion in Myocardial Infarction Trial: The CRIT Pilot
NCT00126334
Feasibility and Impact of "ABCs of Diabetes" Self-Management Education Program at an Urban Public Library
NCT00822471
Vinorelbine and Docetaxel in Treating Women With Metastatic Breast Cancer
NCT00006682
Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer
NCT00006472
Combination Chemotherapy and Radiation Therapy Followed By Surgery in Treating Patients With Stage IIB or Stage IIIA Non-Small Cell Lung Cancer
NCT00006469
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 15 |
| Phase 3 | 4 |
| Phase 4 | 12 |
Therapeutic Areas
What is open in the Medstar Health Research Institute pipeline
23 recruiting of 115 indexed (20% open); 65 completed (57%).
Phase mix: 16 late (III/IV) vs 18 early (I/II) (balanced across stages).
Top condition: Neurogenic Bladder (5 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Medstar Health Research Institute: open-pipeline peers nationwide
Peers matched on 115 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
Medstar Health Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 115 trials (± recruiting share)
- Medtronic Cardiac Rhythm and Heart Failure · 115 trials · 2% recruiting
- Zimmer Biomet · 115 trials · 10% recruiting
- Rockefeller University · 117 trials · 4% recruiting
- State University of New York - Upstate Medical University · 113 trials · 7% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Acera Surgical · 20% recruiting · 5 trials
- Align Technology · 20% recruiting · 5 trials
- AltruBio · 20% recruiting · 5 trials
- Alvernia University · 20% recruiting · 5 trials
Related
What to do with this Medstar Health Research Institute page
115 registered trials is a research-attention snapshot, not an endorsement of Medstar Health Research Institute or any single study.
- 23 of Medstar Health Research Institute's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Neurogenic Bladder is the condition Medstar Health Research Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Neurogenic Bladder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Medstar Health Research Institute pipeline card: 115 registered trials from official public datasets.Report a data error.